YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)
Parker Waichman Alonso LLP Headlines by Topic
Trasylol
Trasylol Pulled From World Market by Bayer AG
Nov 7, 2007 | Parker Waichman Alonso LLP
Trasylol, an anti-bleeding medication, was pulled from the market earlier this week following concerns that it put patients at a high risk of...
Trasylol to Undergo another FDA Safety Review After Canada Halts Clinical Trial
Oct 29, 2007 | Parker Waichman Alonso LLP
Trasylol will be the subject of yet another Food & Drug Administration (FDA) safety review, after a clinical trial involving the drug was halted...
Trasylol Clinical Trail Halted Due to Bleeding, Death Risk
Oct 25, 2007 | Parker Waichman Alonso LLP
A Trasylol clinical trial has been halted according to the Food & Drug Administration (FDA) because patients enrolled in the study who took...
Trasylol Should Remain on Market Says FDA Panel, Despite Risk of Kidney Failure and Death
Sep 13, 2007 | Parker Waichman Alonso, LLP
Drug Safety reviewers say Trasylol should remain on the market, despite being linked to an increased risk death. Yesterday, a Food & Drug...
Trasylol Kidney, Death Risks to Be Investigated by FDA Advisory Panel
Sep 11, 2007 | Parker Waichman Alonso, LLP
Trasylol, a drug used to prevent bleeding during heart bypass surgeries that has been linked to kidney failure, will face the scrutiny of a Food...
Heart surgery drug linked to death risk
Feb 7, 2007 | AP
A drug widely used to prevent excessive bleeding during heart surgery appears to raise the risk of dying in the five years afterward by nearly 50...
Costly bypass medication may raise death risk later
Feb 7, 2007 | USA Today
An expensive drug given to coronary artery bypass surgery patients to prevent excessive bleeding is linked to an increased risk of dying as long as...
International study: Five-year death rate higher in heart surgery patients who are given aprotinin
Feb 7, 2007 | Newsday
Patients who are given a widely used drug to prevent excessive bleeding during heart surgery are at increased risk of dying within five years...
Aprotinin, drug used in cardiac surgery, heightens death risk: study
Feb 7, 2007 | AFP
Researchers have found that as drug used to staunch blood loss in patients undergoing cardiac surgery can raise the risk of death over the medium...
Bayer’s Heart-Surgery Drug Increases Risk of Death
Feb 7, 2007 | NewsInferno.com
Bayer’s controversial heart-surgery drug aprotinin, marketed as Trasylol, is under fire yet again thanks to a new study that found that the...
Trasylol
